PharmaHub · Other Pharma & Biotech · Global

Nutrigenomics Testing Market: Market Size & Forecast 2026

The global nutrigenomics testing market is valued at approximately $1.04 billion in 2025 and is projected to grow at a compound annual growth rate of 14.6%, driven by rising consumer demand for personalized nutrition and advances in genetic testing technology. This segment of the broader personalized medicine industry involves analyzing how an individual's genetic makeup influences their response to food and nutrients, enabling tailored dietary recommendations. Growth is fueled by increasing awareness of preventive healthcare, the global rise in diet-related chronic diseases such as obesity and diabetes, and expanding access to direct-to-consumer genetic testing platforms.

Market size · 2025
$1 billion
CAGR · 2025–2030
14.6%
Forecast · 2030
$2.1 billion
Basis
Claight Analysis
Market size (USD)
Base year 2025
Official data · Claight AnalysisForecast
Market size and forecast are Claight Analysis, informed by public research.
Forecast
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2025 base: $1bn2030 est: $2.1bn
Read the full Nutrigenomics Testing Market report →

Market Overview

The nutrigenomics testing market encompasses genetic analysis services that examine variations in genes related to nutrient metabolism, food sensitivities, and dietary response. These tests typically analyze single nucleotide polymorphisms (SNPs) in genes involved in vitamin absorption, fat metabolism, lactose tolerance, and caffeine sensitivity, among other traits. While market size estimates vary across research firms due to differing definitions of scope, with figures ranging from approximately $0.58 billion to $1.99 billion in 2025 depending on whether the analysis includes broader nutrigenomics services or focuses narrowly on testing, the consensus points to robust double-digit growth.

  • Market size estimates for 2025 vary widely, from $537 million to $1.99 billion, reflecting differences in how firms define the market scope (testing-only vs. broader nutrigenomics services)
  • Growth projections range from roughly 10% to 18% CAGR through the early 2030s, with most analysts converging on a range of 14% to 17%
  • The market has attracted attention due to growing consumer interest in precision nutrition and preventive wellness approaches

Growth Drivers

Rising global prevalence of lifestyle-related diseases, including obesity and type 2 diabetes, has increased demand for personalized dietary interventions that account for genetic predispositions. Technological advances in next-generation sequencing and SNP genotyping have substantially reduced the cost of genetic testing, making these services accessible to broader consumer segments. Additionally, growing consumer awareness of the role genetics plays in nutrition, combined with the proliferation of direct-to-consumer health testing platforms, has accelerated adoption rates significantly.

  • Increasing prevalence of chronic diet-related conditions such as obesity has created demand for more effective, individualized nutrition strategies
  • Declining costs of genomic sequencing and genotyping technologies have made nutrigenomics testing commercially viable at wider price points
  • Expanding ecosystem of at-home genetic test kits and connected digital health platforms is lowering barriers to consumer access
Want a deeper cut on Nutrigenomics Testing Market? We build bespoke studies on request.
Connect to an analyst →

Segmentation and Regional Analysis

The market can be segmented by service type, including genetic tests focused on specific health areas such as weight management, gut health, food intolerance, and vitamin metabolism. Geographically, North America represents the largest regional market due to high consumer awareness, established healthcare infrastructure, and a strong presence of direct-to-consumer genetic testing companies. The Asia-Pacific region is expected to exhibit the fastest growth as disposable incomes rise, healthcare access expands, and scientific literacy around genomics increases.

  • North America currently leads in market share, supported by advanced healthcare infrastructure and strong consumer adoption of personalized wellness products
  • Asia-Pacific is projected to be the fastest-growing region, driven by rising health consciousness, growing middle-class populations, and expanding digital health infrastructure
  • Europe maintains a significant presence, with growth supported by established research institutions and increasing regulatory frameworks governing genetic testing services

Trends and Outlook

What are the recent trends and outlook?

Integration of artificial intelligence and machine learning with genomic data is expected to enhance the accuracy and personalization of nutrigenomic recommendations, enabling more sophisticated dietary guidance based on complex genetic and lifestyle interactions. Growing interest in gut microbiome testing alongside traditional genetic testing may lead to more comprehensive personalized nutrition platforms that combine multiple biological data sources. Regulatory scrutiny around the clinical validity of direct-to-consumer genetic testing claims is likely to increase, potentially favoring companies that invest in robust clinical validation and professional partnerships.

  • Emerging multi-omics approaches combining genomics with metabolomics, microbiomics, and lifestyle data aim to deliver more holistic and accurate nutritional guidance
  • Telehealth and digital nutrition platforms increasingly incorporating genetic testing results to offer remote personalized coaching services
  • Growing emphasis on clinical validation and regulatory compliance may reshape the competitive landscape as scrutiny of direct-to-consumer health claims intensifies
Talk to a Claight analyst
Do you want to research Nutrigenomics Testing Market?

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.

Connect to an analyst →

Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.